Literature DB >> 23953110

Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle.

Zachary A Bornholdt1, Takeshi Noda, Dafna M Abelson, Peter Halfmann, Malcolm R Wood, Yoshihiro Kawaoka, Erica Ollmann Saphire.   

Abstract

Proteins, particularly viral proteins, can be multifunctional, but the mechanisms behind multifunctionality are not fully understood. Here, we illustrate through multiple crystal structures, biochemistry, and cellular microscopy that VP40 rearranges into different structures, each with a distinct function required for the ebolavirus life cycle. A butterfly-shaped VP40 dimer traffics to the cellular membrane. Once there, electrostatic interactions trigger rearrangement of the polypeptide into a linear hexamer. These hexamers construct a multilayered, filamentous matrix structure that is critical for budding and resembles tomograms of authentic virions. A third structure of VP40, formed by a different rearrangement, is not involved in virus assembly but instead uniquely binds RNA to regulate viral transcription inside infected cells. These results provide a functional model for ebolavirus matrix assembly and the other roles of VP40 in the virus life cycle and demonstrate how a single wild-type, unmodified polypeptide can assemble into different structures for different functions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23953110      PMCID: PMC4138722          DOI: 10.1016/j.cell.2013.07.015

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  28 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Oligomerization and polymerization of the filovirus matrix protein VP40.

Authors:  Joanna Timmins; Guy Schoehn; Christine Kohlhaas; Hans-Dieter Klenk; Rob W H Ruigrok; Winfríed Weissenhorn
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

Review 3.  Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.

Authors:  Jens H Kuhn
Journal:  Arch Virol Suppl       Date:  2008

4.  Submicrometer Particle Sizing by Multiangle Light Scattering following Fractionation

Authors: 
Journal:  J Colloid Interface Sci       Date:  1998-01-01       Impact factor: 8.128

5.  Investigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis.

Authors:  Emmanuel Adu-Gyamfi; Michelle A Digman; Enrico Gratton; Robert V Stahelin
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

6.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

Authors:  Rekha G Panchal; Gordon Ruthel; Tara A Kenny; George H Kallstrom; Douglas Lane; Shirin S Badie; Limin Li; Sina Bavari; M Javad Aman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

9.  Effect of glycosaminoglycans and PEG on fusion of Sendai virus with phosphatidylserine vesicles.

Authors:  O Zschörnig; K Arnold; S Ohki
Journal:  Biochim Biophys Acta       Date:  1993-05-14

10.  The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties.

Authors:  F Xavier Gomis-Rüth; Andréa Dessen; Joanna Timmins; Andreas Bracher; Larissa Kolesnikowa; Stephan Becker; Hans Dieter Klenk; Winfried Weissenhorn
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

View more
  98 in total

Review 1.  An evolutionary perspective on protein moonlighting.

Authors:  Shelley D Copley
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

Review 4.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

5.  Molecular docking based screening of compounds against VP40 from Ebola virus.

Authors:  Hanaa M Alam El-Din; Samah A Loutfy; Nasra Fathy; Mostafa H Elberry; Ahmed M Mayla; Sara Kassem; Asif Naqvi
Journal:  Bioinformation       Date:  2016-06-15

6.  Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z.

Authors:  Kathryn M Hastie; Michelle Zandonatti; Tong Liu; Sheng Li; Virgil L Woods; Erica Ollmann Saphire
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

7.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

8.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

Review 9.  Technical standards for hepatitis B virus X protein (HBx) research.

Authors:  Betty L Slagle; Ourania M Andrisani; Michael J Bouchard; Caroline G L Lee; J-H James Ou; Aleem Siddiqui
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

10.  The Ebola virus protein VP40 hexamer enhances the clustering of PI(4,5)P2 lipids in the plasma membrane.

Authors:  Jeevan B Gc; Bernard S Gerstman; Robert V Stahelin; Prem P Chapagain
Journal:  Phys Chem Chem Phys       Date:  2016-10-19       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.